173 related articles for article (PubMed ID: 37747017)
1. Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease.
Wang X; Zhao D; Cheng L; Gao J; Li J; Geng C
Medicine (Baltimore); 2023 Sep; 102(38):e34638. PubMed ID: 37747017
[TBL] [Abstract][Full Text] [Related]
2. Blood Levels of the
Ghodsian N; Gagnon E; Bourgault J; Gobeil É; Manikpurage HD; Perrot N; Girard A; Mitchell PL; Arsenault BJ
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959760
[TBL] [Abstract][Full Text] [Related]
3. Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures.
Pei X; Jiang W; Li L; Zeng Q; Liu CH; Wang M; Chen E; Zhou T; Tang H; Wu D
J Gastroenterol Hepatol; 2024 May; 39(5):847-857. PubMed ID: 38240493
[TBL] [Abstract][Full Text] [Related]
4. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.
Liu Z; Zhang Y; Graham S; Wang X; Cai D; Huang M; Pique-Regi R; Dong XC; Chen YE; Willer C; Liu W
J Hepatol; 2020 Aug; 73(2):263-276. PubMed ID: 32165250
[TBL] [Abstract][Full Text] [Related]
5. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
6. Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Zhang Z; Li M; Ji G; Zhang L
Eur J Clin Invest; 2024 Mar; 54(3):e14116. PubMed ID: 37916519
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
8. Causal relationship between nonalcoholic fatty liver disease and different sleep traits: a bidirectional Mendelian randomized study.
Sun Z; Ji J; Zuo L; Hu Y; Wang K; Xu T; Wang Q; Cheng F
Front Endocrinol (Lausanne); 2023; 14():1159258. PubMed ID: 37334291
[TBL] [Abstract][Full Text] [Related]
9. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study.
Tao M; Zhou G; Liu J; He M; Wang C; Luo X; Zhang L
Clin Endocrinol (Oxf); 2023 Oct; 99(4):370-377. PubMed ID: 37559547
[TBL] [Abstract][Full Text] [Related]
10. Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease: Mendelian randomization study.
Xiao XP; Dai YJ; Zhang Y; Yang M; Xie J; Chen G; Yang ZJ
World J Clin Cases; 2024 Mar; 12(7):1215-1226. PubMed ID: 38524522
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
[TBL] [Abstract][Full Text] [Related]
12. Causal Effects of Overall and Abdominal Obesity on Insulin Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization Study.
Xu H; Jin C; Guan Q
Front Genet; 2020; 11():603. PubMed ID: 32714368
[TBL] [Abstract][Full Text] [Related]
13. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
14. Association between leptin and NAFLD: a two-sample Mendelian randomization study.
Guo Z; Du H; Guo Y; Jin Q; Liu R; Yun Z; Zhang J; Li X; Ye Y
Eur J Med Res; 2023 Jul; 28(1):215. PubMed ID: 37400922
[TBL] [Abstract][Full Text] [Related]
15. The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study.
Xie J; Huang H; Liu Z; Li Y; Yu C; Xu L; Xu C
Hepatology; 2023 Mar; 77(3):949-964. PubMed ID: 35971878
[TBL] [Abstract][Full Text] [Related]
16. Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study.
Chen L; Fan Z; Sun X; Qiu W; Mu W; Chai K; Cao Y; Wang G; Lv G
Hepatol Int; 2023 Apr; 17(2):326-338. PubMed ID: 36352064
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.
Yuan S; Chen J; Li X; Fan R; Arsenault B; Gill D; Giovannucci EL; Zheng JS; Larsson SC
Eur J Epidemiol; 2022 Jul; 37(7):723-733. PubMed ID: 35488966
[TBL] [Abstract][Full Text] [Related]
18. Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study.
Ni X; Tong C; Halengbieke A; Cao T; Tang J; Tao L; Zheng D; Han Y; Li Q; Yang X
Diabetes Res Clin Pract; 2023 Dec; 206():110993. PubMed ID: 37931882
[TBL] [Abstract][Full Text] [Related]
19. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome.
Liu D; Gao X; Pan XF; Zhou T; Zhu C; Li F; Fan JG; Targher G; Zhao J
BMC Med; 2023 Feb; 21(1):62. PubMed ID: 36800955
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
